EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies Post author:Sam Post published:April 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 3 Top Diabetes Biotechs to Buy Into Right Now November 26, 2017 BioSig Technologies Release: Company Issues Shareholder Letter January 19, 2017 <b>Kaleido Biosciences</b> Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec September 17, 2017
<b>Kaleido Biosciences</b> Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec September 17, 2017